4.6 Article

Alexander disease: an astrocytopathy that produces a leukodystrophy

Journal

BRAIN PATHOLOGY
Volume 28, Issue 3, Pages 388-398

Publisher

WILEY
DOI: 10.1111/bpa.12601

Keywords

Alexander disease; astrocytes; GFAP; leukodystrophy

Funding

  1. Tuberous Sclerosis Alliance
  2. NIH [PO1NS042803]

Ask authors/readers for more resources

Alexander Disease (AxD) is a degenerative disorder caused by mutations in the GFAP gene, Which encodes the major intermediate filament of astrocytes. As other cells in the CNS do not express GFAP, AxD is a primary astrocyte disease. Astrocytes acquire a large number of pathological features, including changes in morphology, the loss or diminution of a number of critical astrocyte functions and the activation of cell stress and inflammatory pathways. AxD is also characterized by white matter degeneration, a pathology that has led it to be included in the leukodystrophies. Furthermore, variable degrees of neuronal loss take place. Thus, the astrocyte pathology triggers alterations in other cell types. Here, we will review the neuropathology of AxD and discuss how a disease of astrocytes can lead to severe pathologies in non-astrocytic cells. Our knowledge of the pathophysiology of AxD will also lead to a better understanding of how astrocytes interact with other CNS cells and how astrocytes in the gliosis that accompanies many neurological disorders can damage the function and survival of other cells.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available